Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 3
2006 2
2008 1
2009 1
2010 3
2011 4
2012 6
2013 7
2014 9
2015 3
2016 6
2017 5
2018 7
2019 7
2020 7
2021 5
2022 1
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Penack O, Peczynski C, Koenecke C, Polge E, Sanderson R, Yakoub-Agha I, Fegueux N, Daskalakis M, Collin M, Dreger P, Kröger N, Schanz U, Bloor A, Ganser A, Besley C, Wulf GG, Novak U, Moiseev I, Schoemans H, Basak GW, Chabannon C, Sureda A, Glass B, Peric Z. Penack O, et al. Among authors: fegueux n. Front Immunol. 2023 Sep 27;14:1252811. doi: 10.3389/fimmu.2023.1252811. eCollection 2023. Front Immunol. 2023. PMID: 37828980 Free PMC article.
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
Penack O, Peczynski C, Koenecke C, Polge E, Kuhnl A, Fegueux N, Daskalakis M, Kröger N, Dreger P, Besley C, Schanz U, Bloor A, Ganser A, Forcade E, Corral LL, Passweg JR, Novak U, Moiseev I, Schoemans H, Basak GW, Chabannon C, Sureda A, Averbuch D, Glass B, de la Camara R, Peric Z. Penack O, et al. Among authors: fegueux n. J Immunother Cancer. 2023 Apr;11(4):e006406. doi: 10.1136/jitc-2022-006406. J Immunother Cancer. 2023. PMID: 37072350 Free PMC article.
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Beksac M, Iacobelli S, Koster L, Cornelissen J, Griskevicius L, Rabin NK, Stoppa AM, Meijer E, Mear JB, Zeerleder S, Mayer J, Fenk R, Fegueux N, Chevallier P, Konirova E, Snowden JA, Engelhardt M, Orchard K, Hulin C, Schaap N, Sossa C, Elmaagacli A, McLornan DP, Hayden PJ, Schönland S, Yakoub-Agha I. Beksac M, et al. Among authors: fegueux n. Bone Marrow Transplant. 2023 Aug;58(8):916-923. doi: 10.1038/s41409-023-01999-1. Epub 2023 May 9. Bone Marrow Transplant. 2023. PMID: 37160942
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor.
Paviglianiti A, Ngoya M, Peña M, Boumendil A, Gülbas Z, Ciceri F, Bonifazi F, Russo D, Fegueux N, Stolzel F, Bulabois CE, Socié G, Forcade E, Solano C, Finel H, Robinson S, Glass B, Montoto S. Paviglianiti A, et al. Among authors: fegueux n. Bone Marrow Transplant. 2024 May;59(5):597-603. doi: 10.1038/s41409-024-02225-2. Epub 2024 Feb 8. Bone Marrow Transplant. 2024. PMID: 38331980 Free PMC article.
Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Battipaglia G, Labopin M, Mielke S, Ruggeri A, Nur Ozkurt Z, Bourhis JH, Rabitsch W, Yakoub-Agha I, Grillo G, Sanz J, Arcese W, Novis Y, Fegueux N, Spyridonidis A, Giebel S, Nagler A, Ciceri F, Mohty M. Battipaglia G, et al. Among authors: fegueux n. Transplant Cell Ther. 2024 Jan;30(1):95.e1-95.e10. doi: 10.1016/j.jtct.2023.09.028. Epub 2023 Oct 8. Transplant Cell Ther. 2024. PMID: 37816471 Free article.
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment.
Lamure S, Paul F, Gagez AL, Delage J, Vincent L, Fegueux N, Sirvent A, Gehlkopf E, Veyrune JL, Yang LZ, Kanouni T, Cacheux V, Moreaux J, Bonafoux B, Cartron G, De Vos J, Ceballos P. Lamure S, et al. Among authors: fegueux n. J Clin Med. 2020 Jul 12;9(7):2204. doi: 10.3390/jcm9072204. J Clin Med. 2020. PMID: 32664688 Free PMC article.
Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30+ Lymphoma.
Tudesq JJ, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T, Merle C, Fegueux N, Ceballos P, Quittet P, Navarro R, Hillaire-Buys D, Cartron G. Tudesq JJ, et al. Among authors: fegueux n. Open Forum Infect Dis. 2017 Apr 5;4(2):ofx091. doi: 10.1093/ofid/ofx091. eCollection 2017 Spring. Open Forum Infect Dis. 2017. PMID: 28638848 Free PMC article.
CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity.
Krzywinska E, Cornillon A, Allende-Vega N, Vo DN, Rene C, Lu ZY, Pasero C, Olive D, Fegueux N, Ceballos P, Hicheri Y, Sobecki M, Rossi JF, Cartron G, Villalba M. Krzywinska E, et al. Among authors: fegueux n. PLoS One. 2016 Apr 21;11(4):e0150434. doi: 10.1371/journal.pone.0150434. eCollection 2016. PLoS One. 2016. PMID: 27100180 Free PMC article.
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Nagler A, Labopin M, Cornelissen JJ, Forcade E, Chevallier P, Fegueux N, Sierra J, Desmier D, Labussière-Wallet H, Byrne JL, Loschi M, Blaise D, Baron F, Ruggeri A, Mohty M. Nagler A, et al. Among authors: fegueux n. Bone Marrow Transplant. 2022 Oct;57(10):1514-1519. doi: 10.1038/s41409-022-01742-2. Epub 2022 Jun 30. Bone Marrow Transplant. 2022. PMID: 35773347 Free article.
72 results